📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Using an NMR metabolomics approach to investigate the pathogenicity of amyloid-beta and alpha-synuclein (2017)

First Author: Phelan M

Attributed to: MICA: Applying innovative technologies to improve benefit-risk ratio of drugs: developing a national resource underpinned by the MRC Centre for CDSS funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s11306-017-1289-5

PubMed Identifier: 29142509

Publication URI: http://europepmc.org/abstract/MED/29142509

Type: Journal Article/Review

Parent Publication: Metabolomics

Issue: 12

ISSN: 1573-3882